-
Sector Analysis
KOL Perspectives: Dose Tapering Strategies in Rheumatoid Arthritis
› This KOL Insight briefing focuses on dose tapering strategies in patients receiving targeted therapy for rheumatoid arthritis (RA)
-
Product Insights
Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) Global Clinical Trials Review, H2, 2017" provides an overview of Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Mucocutaneous Lymph Node Syndrome (Kawasaki Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase,...
-
Product Insights
Kidney Transplant Rejection Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Kidney Transplant Rejection Global Clinical Trials Review, H2, 2017" provides an overview of Kidney Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical trials on Kidney Transplant Rejection. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Lambert–Eaton Myasthenic Syndrome (LEMS) Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Lambert–Eaton Myasthenic Syndrome (LEMS) Global Clinical Trials Review, H2, 2017" provides an overview of Lambert–Eaton Myasthenic Syndrome (LEMS) clinical trials scenario. This report provides top line data relating to the clinical trials on Lambert–Eaton Myasthenic Syndrome (LEMS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Milk Allergy Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Milk Allergy Global Clinical Trials Review, H2, 2017" provides an overview of Milk Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on Milk Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Allergies Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Allergies Global Clinical Trials Review, H1, 2017" provides an overview of Allergies clinical trials scenario. This report provides top line data relating to the clinical trials on Allergies. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H1, 2017" provides an overview of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) clinical trials scenario. This report provides top line data relating to the clinical trials on Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase,...
-
Product Insights
Angioedema Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Angioedema Global Clinical Trials Review, H1, 2017" provides an overview of Angioedema clinical trials scenario. This report provides top line data relating to the clinical trials on Angioedema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Birch Pollen Allergy Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Birch Pollen Allergy Global Clinical Trials Review, H1, 2017" provides an overview of Birch Pollen Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on Birch Pollen Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Sector Analysis
EpiCast Report: Rheumatoid Arthritis – Epidemiology Forecast to 2025
Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body. In RA, the body's immune system attacks the lining of the joints, known as the synovial membrane, or synovium, causing an inflammatory response. The disease can lead to premature mortality, disability, and decreased quality of life. In the 8MM, GlobalData epidemiologists forecast that the diagnosed incident cases of RA...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.